ClinicalTrials.Veeva

Menu

Electrocardiogram Clinical Validation Study

A

Apple

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Other: 1-Lead ECG
Device: 12-Lead ECG

Study type

Interventional

Funder types

Industry

Identifiers

NCT03492554
099-11774

Details and patient eligibility

About

The purpose of the study is to confirm the software's ability to create a Lead-1 electrocardiogram (ECG) that is clinically equivalent to a reference device. Also, to confirm a rhythm classification algorithm and its ability to detect and classify heart rhythms into two categories (Sinus Rhythm or Atrial Fibrillation) using a single Lead ECG.

Enrollment

602 patients

Sex

All

Ages

22+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Individuals who are 22 years of age and older
  • Able to read, understand, and provide written informed consent
  • Willing and able to participate in the study procedures as described in the consent
  • Have a wrist circumference that fits within the band
  • Able to communicate effectively with and follow instructions from the study staff
  • For subjects enrolled into the AF population, subjects must have a known diagnosis of AF and be in AF at the time of screening

Exclusion criteria

  • Physical disability that precludes safe and adequate testing
  • Mental impairment resulting in limited ability to cooperate
  • Subjects with a pacemaker or implantable cardioverter-defibrillator (ICD)
  • Acute myocardial infarction (MI) within 90 days of screening or other cardiovascular disease that, in the opinion of the Investigator, increases the risk to the subject or renders data uninterpretable
  • Acute pulmonary embolism, pulmonary infarction, or deep vein thrombosis within 90 days of screening
  • Stroke or transient ischemic attack within 90 days of screening
  • Subjects taking rhythm control drugs
  • Symptomatic (or active) allergic skin reactions such as eczema, rosacea, impetigo, dermatomyositis or allergic contact dermatitis on both wrists or over electrode attachment sites
  • Known sensitivity to medical adhesives, isopropyl alcohol, watch bands, or electrocardiogram (ECG) electrodes including known allergy or sensitivity to fluoroelastomer bands primarily used in wrist worn fitness devices
  • A history of abnormal life-threatening rhythms as determined by the investigator
  • Significant tremor that prevents subject from being able to hold still
  • Pregnant women: Women who are pregnant at the time of study participation
  • For subjects enrolled into the sinus rhythm population, they must not have any diagnosis of AF

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

602 participants in 2 patient groups

Atrial fibrillation (AF)
Other group
Description:
Patient with a known history of AF who are in AF at the time of study screening.
Treatment:
Other: 1-Lead ECG
Device: 12-Lead ECG
Normal Sinus Rhythm (SR)
Other group
Description:
Patient with no known diagnosis of AF or other arrhythmia
Treatment:
Other: 1-Lead ECG
Device: 12-Lead ECG

Trial documents
1

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems